Skip to main content

Advertisement

Log in

The Emerging Need for Combined Heart and Liver Transplantation in Congenital Heart Disease

  • Liver Transplantation (D Mulligan and R Batra, Section Editors)
  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Patients with congenital heart disease (CHD) are living longer due to advances in cardiovascular medicine. We sought to review the physiology and evaluation of these CHD patients who demonstrate the emerging need for combined heart and liver transplantation.

Recent Findings

The principal population affected by failing cardiohepatic physiology are those with single-ventricle physiology palliated to Fontan. Patients are evaluated by a multidisciplinary team including transplant cardiology and hepatology to determine the degree of liver damage and necessity of combined heart and liver transplantation. While still only performed at a limited number of centers, early data suggest good graft and patient survival.

Summary

Combined heart and liver transplantation is warranted in a specific subset of patients with CHD. En bloc heart and liver transplantation may offer benefits including reduction in ischemia times. As experience increases, additional guidelines to help direct care for these patients will be warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH III, Book W, et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70:3173–94. https://doi.org/10.1016/j.jacc.2017.10.045.

    Article  PubMed  Google Scholar 

  2. Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134:101–9. https://doi.org/10.1161/CIRCULATIONAHA.115.019307.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hill AL, Maeda K, Bonham CA, Concepcion W. Pediatric combined heart-liver transplantation performed en bloc: a single-center experience. Pediatr Transplant. 2012;16:392–7. https://doi.org/10.1111/j.1399-3046.2012.01695.x.

    Article  PubMed  Google Scholar 

  4. • Vaikunth SS, et al. Short-term outcomes of en bloc combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2019;33(e13540). https://doi.org/10.1111/ctr.13540This study discusses the evaluation and outcomes of both adult and pediatric patient undergoing en bloc combined heart and liver transplantion for failing Fontan physiology.

  5. Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97:1238–43. https://doi.org/10.1016/j.amjcard.2005.10.065.

    Article  PubMed  Google Scholar 

  6. Diamond T, Ovchinsky N. Fontan-associated liver disease: monitoring progression of liver fibrosis. Clin Liver Dis (Hoboken). 2018;11:1–5. https://doi.org/10.1002/cld.681.

    Article  Google Scholar 

  7. Goldberg DJ, et al. Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. 2017;6. https://doi.org/10.1161/JAHA.116.004809.

  8. Jacob KA, Hjortnaes J, Kranenburg G, de Heer F, Kluin J. Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score. Interact Cardiovasc Thorac Surg. 2015;20:520–30. https://doi.org/10.1093/icvts/ivu438.

    Article  PubMed  Google Scholar 

  9. Greenway SC, Crossland DS, Hudson M, Martin SR, Myers RP, Prieur T, et al. Fontan-associated liver disease: implications for heart transplantation. J Heart Lung Transplant. 2016;35:26–33. https://doi.org/10.1016/j.healun.2015.10.015.

    Article  PubMed  Google Scholar 

  10. • Romero R. Liver in congenital heart disease: implications of the fontan procedure for pediatric and adult liver specialists. Clin Liver Dis (Hoboken). 2013;2:210–4. https://doi.org/10.1002/cld.241This article discusses Fontan procedure, physiology, and the downstream effect on liver disease.

  11. Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017;33:158–63. https://doi.org/10.1097/MOG.0000000000000355.

    Article  PubMed  Google Scholar 

  12. Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019;7:87–97. https://doi.org/10.1016/j.jchf.2018.10.007.

    Article  PubMed  Google Scholar 

  13. Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver disease: a review. J Cardiol. 2019;74:223–32. https://doi.org/10.1016/j.jjcc.2019.02.016.

    Article  PubMed  Google Scholar 

  14. McCormick AD, Schumacher KR. Transplantation of the failing Fontan. Transl Pediatr. 2019;8:290–301. https://doi.org/10.21037/tp.2019.06.03.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Alsaied T, Bokma JP, Engel ME, Kuijpers JM, Hanke SP, Zuhlke L, et al. Factors associated with long-term mortality after Fontan procedures: a systematic review. Heart. 2017;103:104–10. https://doi.org/10.1136/heartjnl-2016-310108.

    Article  PubMed  Google Scholar 

  16. Schumacher KR, Kindel SJ. Considerations for advanced heart failure consultation in Fontan patients: guidance for primary cardiologists, <http://www.actionlearningnetwork.org> (2020).

  17. Surrey LF, Russo P, Rychik J, Goldberg DJ, Dodds K, O'Byrne ML, et al. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol. 2016;57:106–15. https://doi.org/10.1016/j.humpath.2016.07.006.

    Article  PubMed  Google Scholar 

  18. Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, et al. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant. 2015;34:873–82. https://doi.org/10.1016/j.healun.2014.12.009.

    Article  PubMed  Google Scholar 

  19. Grimm JC, Magruder JT, Do N, Spinner JA, Dungan SP, Kilic A, et al. Modified model for end-stage liver disease eXcluding INR (MELD-XI) score predicts early death after pediatric heart transplantation. Ann Thorac Surg. 2016;101:730–5. https://doi.org/10.1016/j.athoracsur.2015.06.063.

    Article  PubMed  Google Scholar 

  20. Poterucha JT, Johnson JN, Qureshi MY, O’Leary PW, Kamath PS, Lennon RJ, et al. Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation. Mayo Clin Proc. 2015;90:882–94. https://doi.org/10.1016/j.mayocp.2015.04.020.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ebel NH, et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. J Pediatr Gastroenterol Nutr. 2019;68:788–92. https://doi.org/10.1097/MPG.0000000000002327.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hsia TY, Khambadkone S, Deanfield JE, Taylor JFN, Migliavacca F, de Leval MR. Subdiaphragmatic venous hemodynamics in the Fontan circulation. J Thorac Cardiovasc Surg. 2001;121:436–47. https://doi.org/10.1067/mtc.2001.112527.

    Article  CAS  PubMed  Google Scholar 

  23. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, et al. Liver allograft provides immunoprotection for the cardiac allograft in combined heart-liver transplantation. Am J Transplant. 2016;16:3522–31. https://doi.org/10.1111/ajt.13870.

    Article  CAS  PubMed  Google Scholar 

  24. Gugenheim J, et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation. 1990;50:309–13. https://doi.org/10.1097/00007890-199008000-00027.

    Article  CAS  PubMed  Google Scholar 

  25. • D'Souza BA, et al. Single-center outcomes of combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2017;31. https://doi.org/10.1111/ctr.12892This article evaluates outcomes in adult patients who underwent combined heart and liver transplantation for failing Fontan physiology.

  26. Hollander SA, Reinhartz O, Maeda K, Hurwitz M, N. Rosenthal D, Bernstein D. Intermediate-term outcomes after combined heart-liver transplantation in children with a univentricular heart. J Heart Lung Transplant. 2013;32:368–70. https://doi.org/10.1016/j.healun.2012.11.023.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos O. Esquivel.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Liver Transplantation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Than, P.A., Brubaker, A.L., Ebel, N.H. et al. The Emerging Need for Combined Heart and Liver Transplantation in Congenital Heart Disease. Curr Transpl Rep 7, 180–186 (2020). https://doi.org/10.1007/s40472-020-00286-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-020-00286-y

Keywords

Navigation